140PMetabolic syndrome and inflammation in castration resistant prostate cancer (CRPC) patients (pts) treated with abiraterone (abi) and enzalutamide (enza)
Conteduca, V., Caffo, O., Galli, L., Maugeri, A., Scarpi, E., Maines, F., Chiuri, V., Lolli, C., Kinspergher, S., Schepisi, G., Santoni, M., Santini, D., Fratino, L., Burgio, S.L., Salvi, S., Menna, CVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx363.056
Date:
September, 2017
File:
PDF, 99 KB
english, 2017